Beta cell long intergenic noncoding RNA 1 (BETALINC1)

Beta cell long intergenic noncoding RNA 1 (BETALINC1), also known as HI-LNC15 or Human islet long noncoding RNA 15, is a conserved long noncoding RNA (lncRNA) expressed specifically in pancreatic islets. BETALINC1 plays a critical role in the specification and function of insulin-producing β cells by coordinately regulating several neighboring islet-specific transcription factors, including NKX2.2. Deletion of BETALINC1 in animal models leads to defective islet development, impaired glucose homeostasis, and disruption of insulin secretion, making it essential for normal β-cell biology, but there is no evidence that it is a therapeutic target itself (e.g., a receptor, enzyme, transporter)[1][3]. Key supporting details: - BETALINC1 does not encode a protein; it functions at the RNA level, likely by affecting chromatin organization and gene expression of islet transcriptional networks[1][3]. - BETALINC1 is highly tissue specific and is conserved across mammals[3]. - Knockout and knockdown studies in mice and human β-cell lines show its loss disrupts transcriptional programs necessary for β-cell identity and function[3]. - Although BETALINC1 regulates genes involved in diabetes pathogenesis, there is no report of direct pharmacological interventions targeting this lncRNA, nor is it classified as a canonical druggable target[1][3]. BETALINC1 is therefore best described as a regulatory noncoding RNA crucial for β-cell biology and diabetes risk, rather than a conventional molecular target such as a receptor or enzyme.

Other names

HI-LNC15Human islet long noncoding RNA 15βlinc1